Trial Profile
A research study to assess the mechanism by which Glucovance [glibenclamide/metformin], metformin, and glyburide [glibenclamide] work to control glucose levels in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2007
Price :
$35
*
At a glance
- Drugs Glibenclamide/metformin (Primary) ; Glibenclamide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 10 Jan 2007 Status change
- 16 Oct 2005 New trial record.